dasatinib
Showing 26 - 50 of 229
Mild Cognitive Impairment, Alzheimer Trial in Rochester (Dasatinib, Quercetin)
Enrolling by invitation
- Mild Cognitive Impairment
- Alzheimer Disease
- Dasatinib
- Quercetin
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 2, 2022
Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
- Dasatinib
-
Amman, Jordan
- +4 more
Jan 17, 2022
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +8 more
- cytarabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 28, 2022
Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)
Recruiting
- Acute Lymphoblastic Leukemia
- Dasatinib
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Nov 28, 2022
Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- ABL001
- +2 more
-
Chicago, Illinois
- +5 more
Dec 27, 2021
Metastatic Prostate Cancer Trial in Sydney, Melbourne (Dasatinib, Darolutamide)
Recruiting
- Metastatic Prostate Cancer
- Dasatinib
- Darolutamide
-
Sydney, New South Wales, Australia
- +1 more
May 3, 2022
Stem Cell Transplant Trial in Rochester (Quercetin, Standard of Care - Observation Only, Dasatinib)
Recruiting
- Stem Cell Transplant
- Quercetin
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 18, 2022
Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)
Recruiting
- Acute Lymphoblastic Leukemia
- Philadelphia Chromosome-Positive
- Blinatumomab
- +3 more
-
New York, New York
- +1 more
Nov 10, 2022
Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)
Recruiting
- Metastatic Colorectal Cancer
- Alectinib
- +16 more
-
Oslo, NorwayOslo University Hospital
Feb 10, 2023
Glioblastoma, Recurrent Disease, Recurrent Glioblastoma Trial in Calgary (Afatinib, Dasatinib, Palbociclib)
Not yet recruiting
- Glioblastoma
- +2 more
- Afatinib
- +4 more
-
Calgary, Alberta, CanadaTom Baker Cancer Centre
Jun 24, 2022
Peripheral T Cell Lymphoma Trial in Shanghai (Azacitidine Injection, Dasatinib, Linperlisib)
Recruiting
- Peripheral T Cell Lymphoma
- Azacitidine Injection
- +6 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Nov 8, 2022
Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- Dasatinib
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021
Healthy Trial in Rochester (Dasatinib, Quercetin, Fisetin)
Recruiting
- Healthy
- Dasatinib
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 22, 2022
Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Completed
- Refractory Chronic Lymphocytic Leukemia
- +4 more
- Dasatinib
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 15, 2021
Philadelphia Positive Acute Lymphoblastic Leukemia Trial in Germany (Dasatinib)
Completed
- Philadelphia Positive Acute Lymphoblastic Leukemia
- Dasatinib
-
Stuttgart, Baden-Württemberg, Germany
- +21 more
Jan 10, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- Dasatinib
- +3 more
-
Innsbruck, Austria
- +53 more
Sep 19, 2022
Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic
Terminated
- Recurrent B Acute Lymphoblastic Leukemia
- +3 more
- Cyclophosphamide
- +12 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2022
Chronic Phase Chronic Myeloid Leukemia Trial in Worldwide (Dasatinib)
Completed
- Chronic Phase Chronic Myeloid Leukemia
- Dasatinib
-
Duarte, California
- +27 more
Dec 7, 2021
Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)
Active, not recruiting
- Prostate Cancer
- degarelix
- +3 more
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Aug 25, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Cyclophosphamide
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 18, 2022
Pancreatic Cancer Metastatic Trial in Gainesville (Dasatinib, mFOLFOX6)
Completed
- Pancreatic Cancer Metastatic
- Dasatinib
- mFOLFOX6
-
Gainesville, FloridaUF Health Cancer Center
Dec 3, 2020